1. Von Albert, H.-H. (1982): Die Phenyto-in-Schnellinfusion in der Therapie des Status epilepticus als Behandlungsmethode der ersten Wahl. In: Anästhesie bei Epileptikern und Behandlung des Status epilepticus (Opitz, A., et al., Hrsg.), Basel: Editio-nes „Roche“.
2. Alger, B. E., Nicoll, R. A. (1980): Epileptiform burst after hyperpolarisation: calcium-dependent potassium potential in hippocampal CAi pyramidal cells. Science 210, 1122–1124.
3. Alvin, J., Mchorse, T., Hoyumpa, A., Bush, M. T., Schenker, S. (1975): The Effect of Liver Disease in Man on the Disposition of Phénobarbital. J. Pharmacol. Exp. Ther. 192, 224–235.
4. Anderson, R. J., Raines, A. (1974): Suppression by diphenylhydantoin of afferent discharges arising in muscle spindles of the triceps surae of the cat. J. Pharmacol, exp. Ther. 191, 290–299.
5. Anlezark, G. M., Horton, R. W., Mel-Drum, B. S., Sawaya, M. C. B. (1976): Anticonvulsant action of ethanolamine-O-sul-phate and di-4-propylacetate and the metabolism of y-amino-butyric acid (GABA) in mice with audiogenic seizures. Biochem. Pharmacol. 25, 413–417.